Pharmacokinetic Optimisation of the Treatment of Embolic Disorders
- 1 January 1995
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 28 (1) , 67-92
- https://doi.org/10.2165/00003088-199528010-00006
Abstract
Management of thromboembolic disease involves administration of anticoagulants, thrombolytics or antiplatelet agents to lyse or prevent thrombus extension. Despite widespread use and decades of...Keywords
This publication has 99 references indexed in Scilit:
- Nadroparin Calcium1Drugs, 1992
- EnoxaparinDrugs, 1992
- Heparin Pharmacokinetics and PharmacodynamicsClinical Pharmacokinetics, 1992
- Bioinequivalence of Four 100mg Oral Aspirin Formulations in Healthy VolunteersClinical Pharmacokinetics, 1991
- Intravenous StreptokinaseDrugs, 1990
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- Clinical Pharmacokinetic Considerations in the Control of Oral Anticoagulant TherapyClinical Pharmacokinetics, 1989
- Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial InfarctionNew England Journal of Medicine, 1989
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- Heparin kinetics in venous thrombosis and pulmonary embolism.Circulation, 1976